Argus
•
Oct 28, 2026
LFST: Raising target price to $14.00
Summary
LifeStance Health Group Inc has an Investment Rating of HOLD; a target price of $14.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
ALHC: What does Argus have to say about ALHC?
Oct 28, 2026
•
ALHC
PRVA: Lowering target price to $21.00
Oct 28, 2026
•
PRVA
SHC: What does Argus have to say about SHC?
Oct 28, 2026
•
SHC
ALHC: What does Argus have to say about ALHC?
Oct 21, 2026
•
ALHC
PRVA: Raising target price to $24.00
Oct 21, 2026
•
PRVA
